Next, we quantified tumor cell expansion of hGBM-1, 2, and 3 stimulated with humanin or HNG (using the most efficacious growth-stimulating peptide variant for each hGBM subset; see Figures 2D–2F) in the presence or absence of the GP130 antagonist sc144.24 The gene discussed is MT-RNR2; the disease is neoplasm.